Scarica l'app Stockscreener
98.44
2.53%
-2.55
Dopo l'orario di chiusura:
98.44
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Storia dei dividendi
Precedente Chiudi:
$100.99
Aprire:
$100.47
Volume 24 ore:
2.83M
Relative Volume:
1.29
Capitalizzazione di mercato:
$19.51B
Reddito:
$8.01B
Utile/perdita netta:
$807.20M
Rapporto P/E:
24.36
EPS:
4.0411
Flusso di cassa netto:
$1.13B
1 W Prestazione:
-0.31%
1M Prestazione:
+14.48%
6M Prestazione:
-7.82%
1 anno Prestazione:
-5.39%
Intervallo 1D:
$98.30
$101.31
Intervallo di 1 settimana:
$98.13
$101.49
Portata 52W:
$84.59
$114.44
Zimmer Biomet Holdings Inc Stock (ZBH) Company Profile
Nome
Zimmer Biomet Holdings Inc
Settore
Industria
Telefono
(574) 267-6131
Indirizzo
345 EAST MAIN STREET, WARSAW, IN
Compare ZBH vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ZBH
Zimmer Biomet Holdings Inc
|
98.44 | 20.01B | 8.01B | 807.20M | 1.13B | 4.0411 |
|
ABT
Abbott Laboratories
|
116.35 | 202.16B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
387.46 | 147.74B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
97.66 | 124.39B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
76.85 | 112.40B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
86.47 | 49.85B | 6.07B | 1.06B | 799.60M | 1.8527 |
Zimmer Biomet Holdings Inc Stock (ZBH) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-02-20 | Iniziato | William Blair | Mkt Perform |
| 2026-01-09 | Downgrade | Goldman | Neutral → Sell |
| 2026-01-06 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2026-01-05 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2025-12-16 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2025-11-06 | Downgrade | JP Morgan | Overweight → Neutral |
| 2025-09-18 | Iniziato | Rothschild & Co Redburn | Buy |
| 2025-07-15 | Aggiornamento | Roth Capital | Neutral → Buy |
| 2024-12-17 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2024-09-10 | Iniziato | Wolfe Research | Peer Perform |
| 2024-07-01 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2024-05-30 | Iniziato | Goldman | Neutral |
| 2024-05-21 | Aggiornamento | Argus | Hold → Buy |
| 2024-01-04 | Downgrade | Evercore ISI | Outperform → In-line |
| 2023-10-20 | Iniziato | ROTH MKM | Neutral |
| 2023-08-28 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2023-05-03 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2023-04-11 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2023-03-31 | Aggiornamento | Jefferies | Underperform → Hold |
| 2023-03-29 | Iniziato | UBS | Sell |
| 2023-03-10 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2023-01-09 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-01-05 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2023-01-03 | Downgrade | Evercore ISI | Outperform → In-line |
| 2022-11-23 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2022-10-18 | Iniziato | Barclays | Underweight |
| 2022-10-12 | Iniziato | Jefferies | Underperform |
| 2022-05-27 | Downgrade | Needham | Buy → Hold |
| 2022-04-13 | Downgrade | Truist | Buy → Hold |
| 2022-04-01 | Downgrade | Citigroup | Buy → Neutral |
| 2022-03-02 | Ripresa | BofA Securities | Underperform |
| 2022-03-02 | Downgrade | Loop Capital | Buy → Hold |
| 2022-02-08 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2022-02-08 | Reiterato | Citigroup | Buy |
| 2022-02-08 | Reiterato | Deutsche Bank | Hold |
| 2022-02-08 | Reiterato | JMP Securities | Mkt Outperform |
| 2022-02-08 | Reiterato | JP Morgan | Neutral |
| 2022-02-08 | Reiterato | RBC Capital Mkts | Sector Perform |
| 2022-02-08 | Reiterato | Stifel | Buy |
| 2022-02-08 | Reiterato | Truist | Buy |
| 2022-02-08 | Reiterato | UBS | Neutral |
| 2022-02-08 | Reiterato | Wells Fargo | Underweight |
| 2022-02-02 | Downgrade | UBS | Buy → Neutral |
| 2022-01-19 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| 2022-01-10 | Downgrade | Mizuho | Buy → Neutral |
| 2022-01-07 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2022-01-04 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2021-12-10 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2021-12-09 | Downgrade | Needham | Strong Buy → Buy |
| 2021-12-07 | Iniziato | Loop Capital | Buy |
| 2021-11-23 | Downgrade | Argus | Buy → Hold |
| 2021-09-14 | Ripresa | Raymond James | Mkt Perform |
| 2021-05-25 | Iniziato | Barclays | Overweight |
| 2021-04-09 | Aggiornamento | Northland Capital | Market Perform → Outperform |
| 2021-01-04 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2020-12-18 | Reiterato | Needham | Strong Buy |
| 2020-10-20 | Iniziato | Northland Capital | Market Perform |
| 2020-09-11 | Iniziato | Wolfe Research | Outperform |
| 2020-08-05 | Reiterato | Needham | Strong Buy |
| 2020-04-28 | Downgrade | Guggenheim | Buy → Neutral |
| 2020-04-09 | Downgrade | Evercore ISI | Outperform → In-line |
| 2020-04-07 | Reiterato | Needham | Strong Buy |
| 2020-03-05 | Iniziato | Citigroup | Buy |
| 2020-02-13 | Iniziato | Goldman | Buy |
| 2020-01-08 | Iniziato | SunTrust | Buy |
| 2020-01-07 | Aggiornamento | Piper Jaffray | Neutral → Overweight |
| 2020-01-07 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2019-12-04 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2019-10-07 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2019-09-18 | Aggiornamento | Canaccord Genuity | Hold → Buy |
| 2019-08-12 | Aggiornamento | Argus | Hold → Buy |
| 2019-07-30 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2019-07-29 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2019-06-11 | Aggiornamento | Bernstein | Underperform → Mkt Perform |
| 2019-04-24 | Aggiornamento | Needham | Buy → Strong Buy |
Mostra tutto
Zimmer Biomet Holdings Inc Borsa (ZBH) Ultime notizie
Zimmer Biomet’s ROSA Knee v1.5 Pilot Study: What the Latest Update Signals for ZBH Investors - TipRanks
Pre-market top loser ZBH.SW Zimmer Biomet -4.26% on 27 Feb 2026: support CHF67.50 - Meyka
How The Zimmer Biomet (ZBH) Story Is Shifting As Analysts Debate Growth And Margins - Yahoo Finance
Zimmer Biomet Showcases Robotics And Smart Implants At AAOS 2026 Event - simplywall.st
Zimmer Biomet to Release New Data, Highlight Key Innovations at American Academy of Orthopaedic Surgeons Annual Meeting - PR Newswire
Magellan Asset Management Ltd Raises Holdings in Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Zimmer Biomet (ZBH) officer granted 10,076 restricted stock units vesting from 2027 - Stock Titan
ZBH.SW Zimmer Biomet (SIX) at CHF75.00 24 Feb 2026: volume spike tests resistance - Meyka
JPMorgan Chase & Co. Decreases Stake in Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) to Issue Quarterly Dividend of $0.24 - MarketBeat
Zimmer Biomet Announces Quarterly Dividend for First Quarter of 2026, Payable on or About April 30, 2026 - marketscreener.com
Zimmer Biomet Keeps Quarterly Dividend at $0.24 a Share, Payable April 30 to Holders of Record as of March 31 - marketscreener.com
Zimmer Biomet Announces Quarterly Dividend for First Quarter of 2026 - PR Newswire
Hagens Berman Investigates Zimmer Biomet Over Alleged Emerging Market Failures - National Today
Zimmer Biomet Holdings, Inc. $ZBH Shares Bought by AMG National Trust Bank - MarketBeat
Decoding Zimmer Biomet Holdings Inc (ZBH): A Strategic SWOT Insi - GuruFocus
Zimmer Biomet’s New Stemless Shoulder Study Signals Strategic Push in Joint Reconstruction - The Globe and Mail
Vanguard Group Inc. Acquires 39,929 Shares of Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Skandinaviska Enskilda Banken AB publ Has $6.12 Million Stock Holdings in Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
William Blair Initiates Zimmer Biomet Holdings at Market Perform - marketscreener.com
William Blair initiates Zimmer Biomet stock rating at Market Perform - Investing.com
ZIMMER BIOMET HOLDINGS, INC. SEC 10-K Report - TradingView
3 Reasons to Avoid ZBH and 1 Stock to Buy Instead - Finviz
Zimmer Biomet tops Q4 expectations but strikes measured tone on 2026 guidance - MSN
ZBH Investor Alert: Hagens Berman Investigates Zimmer Biomet (ZB - GuruFocus
Zimmer Biomet Launches Advancement for Hindfoot Fusion - Ortho Spine News
ZBH Investor Alert: Hagens Berman Investigates Zimmer Biomet (ZBH) Over Alleged Emerging Market Failures and "Inconsistent" Execution - marketscreener.com
Zimmer Biomet outlines 2026 revenue growth of 1%–3% amid US sales force overhaul and innovation cycle - MSN
Zimmer Biomet, Paragon 28 announce commercial launch of curved TTC nail system - MassDevice
The Top 5 Analyst Questions From Zimmer Biomet's Q4 Earnings Call - Finviz
There May Be Reason For Hope In Zimmer Biomet Holdings' (NYSE:ZBH) Disappointing Earnings - Yahoo Finance
Institution Moves: Will Zimmer Biomet Holdings Inc outperform its industry peersWeekly Stock Report & Intraday High Probability Setup Alerts - baoquankhu1.vn
The Top 5 Analyst Questions From Zimmer Biomet’s Q4 Earnings Call - Yahoo Finance
ABN Amro Investment Solutions Sells 11,020 Shares of Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Zimmer Biomet stock: Is Wall Street bullish or bearish? - MSN
Why Zimmer Biomet Holdings Inc. stock is favored by hedge fundsWeekly Gains Summary & Accurate Buy Signal Notifications - mfd.ru
Can Zimmer Biomet Holdings Inc. stock surprise with earnings upside2025 Valuation Update & Precise Trade Entry Recommendations - mfd.ru
Is Zimmer Biomet Holdings Inc. exposed to political riskPortfolio Growth Summary & High Return Trade Guides - mfd.ru
Why Zimmer Biomet Holdings Inc. stock could be next big winner2025 Major Catalysts & AI Powered Trade Plan Recommendations - mfd.ru
Zimmer Biomet (NYSE:ZBH) Downgraded to "Hold" Rating by Wall Street Zen - MarketBeat
Update Report: Is Zimmer Biomet Holdings Inc stock a value trap2025 Volume Leaders & Weekly Top Stock Performers List - baoquankhu1.vn
ZBH.SW Zimmer Biomet (SIX) at CHF67.50 pre-market on volume spike: Feb 2026 outlook - Meyka
Zimmer Biomet Stock: Is Wall Street Bullish or Bearish? - Barchart.com
Market Participants Recognise Zimmer Biomet Holdings, Inc.'s (NYSE:ZBH) Earnings - 富途牛牛
Skylands Capital LLC Sells 20,100 Shares of Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Sound Shore Management Inc CT Decreases Stake in Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Johnson Investment Counsel Inc. Lowers Stock Holdings in Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Envestnet Asset Management Inc. Grows Stock Position in Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Zimmer Biomet Expects Paragon 28 To Power Double Digit Rise In 2026 - Citeline News & Insights
Zimmer Biomet Holdings Inc (ZBH) Q4 2025 Earnings Call Highlight - GuruFocus
Analysts Have Conflicting Sentiments on These Healthcare Companies: Zimmer Biomet Holdings (ZBH) and OrganiGram Holdings (OGI) - The Globe and Mail
Zimmer Biomet Holdings Inc Azioni (ZBH) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.92%
0.42%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):